Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Aptamer-based point-of-care detection of inflammatory biomarkers
FY 2021-22
Summary
Although inflammation is the bodys natural defense against infection, severe infections can lead to uncontrolled systemic inflammation, known as sepsis. Sepsis is often fatal and every year causes millions of deaths worldwide; however, because it is only diagnosed via physiological signs, there are no readily available methods for sepsis diagnosis at its early stages. A promising method for early on-stage diagnosis of diseases is active monitoring of changes in the levels of disease biomarkers present in the blood. This method, however, requires biomarker measurements multiple times per day, and conventional monitoring techniques do not allow for proper routine screening. Therefore, I propose a research project that will lead to the development of affordable and effective molecular sensors applicable in the routine monitoring of four inflammatory biomarkers (IBs). Our unique approach will involve the use of DNA aptamers, which are short single-stranded DNA molecules that bind a molecular target with high specificity and affinity. The Krylov group has already developed many highly efficient methods for selecting high-affinity aptamers to protein analytes, such as IBs. Two aptamers will be selected per IB, each binding opposite sides of their respective IB, and both will be conjugated to nanoparticles (NPs). The aptamer-NP conjugates will bind their respective IB on both sides to form highly stable complexes that are detectable for routine monitoring of IB levels. The proposed aptamer-NP conjugates are robust molecular sensors that will be applicable in the development of affordable and effective diagnostic tests for early on-stage diagnosis of sepsis. Success of this project will also provide a basis for diagnostic sensor design for biomarkers of other diseases.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466510
Name
Everton Daniel
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Aptamer-based point-of-care detection of inflammatory biomarkers
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aptamer-Based Detection; Aptamers; Biomolecular Interactions; Capillary Electrophoresis; Inflammation; Inflammatory Biomarker; Nanoparticle; Point-Of-Care; Sandwich Complex; Sepsis
Abstract
Although inflammation is the bodys natural defense against infection, severe infections can lead to uncontrolled systemic inflammation, known as sepsis. Sepsis is often fatal and every year causes millions of deaths worldwide; however, because it is only diagnosed via physiological signs, there are no readily available methods for sepsis diagnosis at its early stages. A promising method for early on-stage diagnosis of diseases is active monitoring of changes in the levels of disease biomarkers present in the blood. This method, however, requires biomarker measurements multiple times per day, and conventional monitoring techniques do not allow for proper routine screening. Therefore, I propose a research project that will lead to the development of affordable and effective molecular sensors applicable in the routine monitoring of four inflammatory biomarkers (IBs). Our unique approach will involve the use of DNA aptamers, which are short single-stranded DNA molecules that bind a molecular target with high specificity and affinity. The Krylov group has already developed many highly efficient methods for selecting high-affinity aptamers to protein analytes, such as IBs. Two aptamers will be selected per IB, each binding opposite sides of their respective IB, and both will be conjugated to nanoparticles (NPs). The aptamer-NP conjugates will bind their respective IB on both sides to form highly stable complexes that are detectable for routine monitoring of IB levels. The proposed aptamer-NP conjugates are robust molecular sensors that will be applicable in the development of affordable and effective diagnostic tests for early on-stage diagnosis of sepsis. Success of this project will also provide a basis for diagnostic sensor design for biomarkers of other diseases.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Everton, Daniel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~